The traditional view of the brain as an isolated organ, protected by the blood-brain barrier and operating independently from peripheral systems, has given way to a more integrated understanding of brain-body interactions. Growing evidence from neuroimaging studies demonstrates that systemic diseases profoundly affect brain structure and function, while brain disorders can reciprocally influence peripheral organ systems through neural, endocrine, and immune pathways.
Magnetic resonance imaging (MRI) has emerged as a powerful tool for investigating brain-body interactions in vivo. Structural MRI reveals changes in brain volume, cortical thickness, and white matter integrity associated with systemic diseases. Functional MRI (fMRI) captures alterations in brain activity and connectivity patterns. Advanced techniques such as diffusion tensor imaging (DTI) and magnetic resonance spectroscopy (MRS) provide additional insights into microstructural changes and metabolic alterations, respectively.
Cardiovascular diseases represent a prime example of brain-body interactions. Hypertension, atherosclerosis, and heart failure are all associated with characteristic patterns of brain changes, including white matter hyperintensities, reduced gray matter volume, and altered cerebral blood flow. These changes often precede clinical cognitive impairment, suggesting that neuroimaging could serve as an early biomarker for cardiovascular-related brain injury. The concept of the "cardi brain" emphasizes the intimate connection between cardiac and cerebral health.
Metabolic disorders, particularly diabetes and obesity, also exert profound effects on the brain. Chronic hyperglycemia and insulin resistance are associated with accelerated brain aging, increased risk of dementia, and specific patterns of neurodegeneration. Neuroimaging studies have revealed reduced hippocampal volume, altered white matter integrity, and disrupted functional connectivity in patients with type 2 diabetes. These findings underscore the importance of metabolic health for brain health and suggest potential targets for intervention.
Autoimmune diseases provide another window into brain-body interactions. Systemic inflammation can breach the blood-brain barrier, leading to neuroinflammation and neuronal dysfunction. Conditions such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis are associated with characteristic neuroimaging findings that reflect both direct immune-mediated damage and secondary effects of chronic inflammation. The emerging field of psychoneuroimmunology seeks to understand these complex interactions and their clinical implications.
Infectious diseases, as dramatically illustrated by the COVID-19 pandemic, can have lasting effects on brain health. Neuroimaging studies of COVID-19 survivors have revealed changes in brain structure and function that persist months after acute infection. Similar observations have been made for other viral and bacterial infections, highlighting the vulnerability of the brain to systemic infectious processes.
The clinical implications of these findings are substantial. Neuroimaging biomarkers could enable early detection of brain involvement in systemic diseases, guide treatment selection, and monitor therapeutic response. Conversely, understanding brain-body interactions opens new avenues for treating brain disorders through systemic interventions. The bidirectional nature of these relationships suggests that interventions targeting either the brain or the body may have beneficial effects on both.
Future directions in this field include the integration of multi-modal imaging data, development of machine learning algorithms for pattern recognition, and longitudinal studies to establish causal relationships. The ultimate goal is to translate these insights into clinical practice, improving diagnosis, prognosis, and treatment for patients with conditions affecting both brain and body.
DOI:10.1007/s11684-026-1229-8